Regulators are stepping in to tighten guardrails around telehealth, warning high-volume prescribing, privacy blind spots and profit-driven models could compromise patient safety.
Regulators are stepping in to tighten guardrails around telehealth, warning high-volume prescribing, privacy blind spots and profit-driven models could compromise patient safety.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.